Graphite Bio, Inc. [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Dec-05-22	Sep-30-22	Sep-05-22	Jun-30-22	Mar-31-22
	10-Q	10-Q	10-K	8-K	10-Q	8-K	10-Q	10-Q
Revenues	0.0	18.5	18.3		0.0		0.0	11.2
Revenue growth		64.8%	110.8%
Cost of goods sold	0.0	26.8	26.2		0.0		0.0	18.9
Gross profit	0.0	0.0	0.0		0.0		0.0	0.0
Gross margin		-44.9%	-42.9%					-69.0%
Selling, general and administrative [+]	137.5	106.1	105.6		97.8		86.3	77.0
Sales and marketing	110.8	79.4			78.9		67.3	58.1
General and administrative			34.6
Other operating expenses	-18.0	0.5	4.2		-4.9		-2.0	3.2
EBITDA [+]	-116.7	-89.6	-94.1		-90.9		-82.8	-75.7
EBITDA growth	41.0%	25.0%	63.8%		84.4%		114.1%	237.3%
EBITDA margin		-512.4%	-533.9%					-678.3%
Depreciation and amortization	2.8	2.6	2.4		2.0		1.5	1.1
EBIT [+]	-119.5	-92.2	-96.5		-92.9		-84.3	-76.7
EBIT growth	41.8%	25.7%	64.6%		86.6%		116.3%	237.5%
EBIT margin		-522.6%	-543.2%					-685.1%
Other income (expense), net	-9.0	-4.8	-3.1		-2.4		-1.0	-0.1
Pre-tax income	-128.5	-99.2	-101.1		-95.4		-85.3	-76.9
Income taxes	0.0	0.0	0.0		0.0		0.0	0.0
Tax rate	0.0%	0.0%	0.0%		0.0%		0.0%	0.0%
Net income	-128.5	-99.2	-101.1		-95.4		-85.3	-76.9
Net margin		-537.1%	-552.1%					-686.2%

Basic EPS [+]	($2.31)	($1.79)	($1.85)		($1.98)		($1.79)	($1.86)
Growth	28.8%	-3.3%	-41.1%		-72.7%		-93.9%	-92.9%
Diluted EPS [+]	($2.31)	($1.79)	($1.85)		($1.98)		($1.79)	($1.86)
Growth	28.8%	-3.3%	-41.1%		-72.7%		-93.9%	-92.9%

Shares outstanding (basic) [+]	55.7	55.3	54.7		48.2		47.6	41.3
Growth	17.0%	57.2%	142.4%		203.2%		1242.0%	1347.3%
Shares outstanding (diluted) [+]	55.7	55.3	54.7		48.2		47.6	41.3
Growth	17.0%	57.2%	142.4%		203.2%		1242.0%	1347.3%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.